Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2012
04/26/2012US20120101122 Imidazo[1,2 a] pyridine 6 carboxamide derivatives, their use for the treatment of colon cancer and their method of manufacture
04/26/2012US20120101121 drug demonstrating anxiolytic effect based on hydrogenated pyrido (4,3-b) indoles, its pharmacological compound and application method
04/26/2012US20120101120 Pure isomers of tritoqualine
04/26/2012US20120101119 N-substituted indenoisoquinolines and syntheses thereof
04/26/2012US20120101118 Tamper resistant dosage forms
04/26/2012US20120101117 Methylenedioxybenzo [i] phenanthridine derivatives used to treat cancer
04/26/2012US20120101116 Substituted heterocyclic compounds as kinases inhibitors and methods of use thereof
04/26/2012US20120101115 Compounds For Inducing Cellular Apoptosis
04/26/2012US20120101114 Inhibitors of bruton's tyrosine kinase
04/26/2012US20120101113 Inhibitors of bruton's tyrosine kinase
04/26/2012US20120101112 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
04/26/2012US20120101111 Novel oxazolidinone deriviatives
04/26/2012US20120101110 Diaza-spiro[5.5]undecanes
04/26/2012US20120101109 Ethanolamine salt of n- (3-methoxy-5-methylpyrazin-2yl) -2- (4-[1, 3, 4-oxadiazole-2-yl] phenyl) pyridine-3- sulphonamide
04/26/2012US20120101108 Anaplastic Lymphoma Kinase In Kidney Cancer
04/26/2012US20120101107 Piperazine dithioctate and pharmaceutical composition comprising the same
04/26/2012US20120101106 Tetrahydronapthyridine Orexin Receptor Antagonists
04/26/2012US20120101105 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
04/26/2012US20120101104 Topical gel compositions and methods of use
04/26/2012US20120101103 7-phenoxychroman carboxylic acid derivatives
04/26/2012US20120101102 Method for predicting therapeutic effect of chemotherapy on renal cell cancer
04/26/2012US20120101101 Therapeutic agent for motor disorders
04/26/2012US20120101100 Heterocyclic urea derivatives and methods of use thereof-211
04/26/2012US20120101099 Histone deacetylase inhibitors
04/26/2012US20120101098 3,28-disubstituted betulinic acid derivatives as anti-hiv agents
04/26/2012US20120101097 Aryl sulfonamides
04/26/2012US20120101096 Compounds and Methods for Treating Mammalian Gastrointestinal Microbial Infections
04/26/2012US20120101095 Alkoxy-thienopyrimidines as tgf-beta receptor kinase modulators
04/26/2012US20120101094 Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
04/26/2012US20120101093 Substituted imidazo[1,2-a]pyridine derivatives, pharmaceutical compositions, and methods of use as beta-secretase inhibitors
04/26/2012US20120101092 Small molecule inhibitors of mdm2 and the uses thereof
04/26/2012US20120101091 Viral polymerase inhibitors
04/26/2012US20120101090 Crystal of a benzoxazinone compound
04/26/2012US20120101089 Anti-Emetic Substance
04/26/2012US20120101088 Transmembrane Penetration Enhancer
04/26/2012US20120101086 Thiadiazole derivatives and their use for the treatment of disorders mediated by s1p1 receptors
04/26/2012US20120101085 Compounds And Methods For Modulating Activity Of Calcium Release Channels
04/26/2012US20120101084 Biological Markers Predictive of Anti-Cancer Response to Insulin-Like Growth Factor-1 Receptor Kinase Inhibitors
04/26/2012US20120101083 S1p1 agonists comprising a bicyclic n-containing ring
04/26/2012US20120101082 Vasopressin v1a antagonists
04/26/2012US20120101081 Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitors
04/26/2012US20120101080 Composition for treatment of tuberculosis
04/26/2012US20120101079 Substituted 6-amino-nicotinamides as kcnq2/3 modulators
04/26/2012US20120101078 Amide derivatives as neuropeptide y5 receptor ligands
04/26/2012US20120101077 Agglomerate formulations useful in dry powder inhalers
04/26/2012US20120101076 Carbonate derivatives for the treatment of cough
04/26/2012US20120101075 Derivatives of 4-(2-Amino-1-Hydroxyethyl) Phenol as Agonists of the Beta2 Adrenergic Receptor
04/26/2012US20120101074 Method and medication for prevention and treatment of ocular hypertension and glaucoma
04/26/2012US20120101073 Novel Method For Treating Breathing Disorders or Diseases
04/26/2012US20120101072 Triazole compounds that modulate hsp90 activity
04/26/2012US20120101071 SubstitutedTetracycline Compounds for the Treatment of Malaria
04/26/2012US20120101070 11a, 12-Derivatives of Tetracycline Compounds
04/26/2012US20120101069 Hemodialysis and peritoneal dialysis solutions comprising one or more creatine compounds
04/26/2012US20120101068 Diphenyl sulfide derivatives and medicines containing same as active ingredient
04/26/2012US20120101067 Methods for enhancing hematopoietic progenitor cell engraftment
04/26/2012US20120101066 Pharmaceutical Compositions and Therapeutic Methods Employing a Combination of a Manganese Complex Compound and a Non-Manganese Complex Form of the Compound
04/26/2012US20120101065 Inhibitors of tyrosine kinases and uses thereof
04/26/2012US20120101064 Imidazole derivatives and their use as modulators of cyclin dependent kinases
04/26/2012US20120101062 Lipase Inhibitors
04/26/2012US20120101061 Compositions and methods for the treatment of inflammation
04/26/2012US20120101060 Skin protectant, particularly against hydrophobic (lipophilic) and against hydrophilic (lipophobic) harmful substances
04/26/2012US20120101059 Sulphated hyaluronic acids as regulator agents of the cytokine activity
04/26/2012US20120101058 Pharmaceutical Composition For Prevention Or Treatment Of Lifestyle-Related Disease, And Food Useful For Prevention Or Treatment Of Lifestyle-Related Disease
04/26/2012US20120101057 Combined therapy of colorectal carcinoma
04/26/2012US20120101056 Medicinal Cream Made Using Framycetin Sulphate and Chitosan and a Process to Make the Same
04/26/2012US20120101055 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
04/26/2012US20120101054 Novel Sodium Channel Blocking Compounds Tetrodotoxin Galactopyranosides
04/26/2012US20120101053 Cathepsin cysteine protease inhibitors for the treatment of various diseases
04/26/2012US20120101052 15-thia steroid compounds and compositions
04/26/2012US20120101051 Novel c-aryl glucoside sglt2 inhibitors and pharmaceutical compositions comprising same
04/26/2012US20120101039 Calcium-sensing receptor-active compounds
04/26/2012US20120101024 Methods and Compositions for Differentiating Embryonic Stem Cells
04/26/2012US20120100234 Non-occluding nasal moisturizer and methods of use
04/26/2012US20120100229 Treatment and Prevention of White Matter Injury with KATP Channel Activators
04/26/2012US20120100227 Kinase protein binding inhibitors
04/26/2012US20120100223 Lipid-containing compositions and methods of use thereof
04/26/2012US20120100221 Pharmaceutical compositions containing a combination of an antihistamine and a decongestant
04/26/2012US20120100220 Drug composition for treating tumor with polymeric micelle encapsulating anti-neoplastic
04/26/2012US20120100218 Intralymphatic Chemotherapy Drug Carriers
04/26/2012US20120100217 Polymeric material
04/26/2012US20120100214 Sustained-Release Tablet and Process for Preparing the Same
04/26/2012US20120100213 Pharmaceutical formulations of a substituted diaminopurine
04/26/2012US20120100209 Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride
04/26/2012US20120100208 Stable pharmaceutical composition and methods of using same
04/26/2012US20120100207 Process for producing liposomes by two-step emulsification method utilizing outer aqueous phase containing specific dispersing agent, process for producing liposome dispersion or dry powder thereof using the process for producing liposomes, and liposome dispersion or dry powder thereof produced thereby
04/26/2012US20120100206 Targeted liposomes comprising n-containing bisphosphonates and uses thereof
04/26/2012US20120100205 Components for producing amphoteric liposomes
04/26/2012US20120100204 TGF-Beta Stimulating Agent Compositions and Combinations
04/26/2012US20120100199 Method for treating a periodontal disease
04/26/2012US20120100192 Local therapeutic release device
04/26/2012US20120100191 Methods and devices for delivery of pharmaceutical agents within orifices of the body
04/26/2012US20120100190 Controlled release sterile injectable aripiprazole formulation and method
04/26/2012US20120100189 Delayed release rasagiline malate formulation
04/26/2012US20120100188 Solid state forms of paliperidone salts and process for the preparation thereof
04/26/2012US20120100187 Coatings and methods for controlled elution of hydrophilic active agents
04/26/2012US20120100184 Synthesis of 1-amino-1,3,3,5,5,-cyclohexane mesylate
04/26/2012US20120100183 Topical base and active agent-containing compositions, and methods for improving and treating skin
04/26/2012US20120100182 Continuous Cell Programming Devices
04/26/2012US20120100175 Antrocin containing pharmaceutical compositions for inhibiting cancer cells
04/26/2012US20120100162 Cyclophosphamide in Combination with Immune Therapeutics
1 ... 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 ... 7860